U-Neuron Biomedical (ROCO:6973) Notes Receivable: NT$0.00 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6973 U-Neuron Biomedical Inc ROCO:6973
32 GF Score
Price NT$41.35
GF Value NT$70.22
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is U-Neuron Biomedical Notes Receivable?

U-Neuron Biomedical ROCO:6973 +4.68% 32 Notes Receivable is NT$0.00 Mil as of Jun. 2026. GuruFocus rates ROCO:6973 with a GF Score™ of 32/100 and a GF Value™ of NT$70.22 (Possible Value Trap). The stock has 3 warning signs investors should review.

U-Neuron Biomedical's Notes Receivable for the quarter that ended in Jun. 2026 was NT$0.00 Mil.

U-Neuron Biomedical Notes Receivable Related Terms

U-Neuron Biomedical Notes Receivable Historical Data

* Premium members only.

The historical data trend for U-Neuron Biomedical's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical Notes Receivable Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

U-Neuron Biomedical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:6973
32GF Score
U-Neuron Biomedical Inc ROCO:6973
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

U-Neuron Biomedical Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of NT$0.00 Mil mean?
U-Neuron Biomedical (ROCO:6973) has a Notes Receivable of NT$0.00 Mil as of Jun. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on U-Neuron Biomedical and its competitors.
Is U-Neuron Biomedical's Notes Receivable too high?
U-Neuron Biomedical's current Notes Receivable is NT$0.00 Mil. Overall, U-Neuron Biomedical has a GF Score™ of 32/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does U-Neuron Biomedical's Notes Receivable compare to VRTX and REGN?
U-Neuron Biomedical's Notes Receivable of NT$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on U-Neuron Biomedical and its competitors. U-Neuron Biomedical's current Notes Receivable is NT$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is U-Neuron Biomedical stock overvalued right now?
Based on GuruFocus' analysis, U-Neuron Biomedical (ROCO:6973) is currently considered Possible Value Trap. The stock's GF Value™ is NT$70.22, compared to a current price of NT$41.35 — trading 41.1% below its estimated fair value. The current Notes Receivable is NT$0.00 Mil. U-Neuron Biomedical's overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For U-Neuron Biomedical (ROCO:6973), the current Notes Receivable is NT$0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is U-Neuron Biomedical (ROCO:6973) Overvalued in 2026?

Based on GuruFocus' analysis, U-Neuron Biomedical stock appears to be undervalued. The current stock price of NT$41.35 is trading 41.1% below its estimated GF Value™ of NT$70.22. GuruFocus considers U-Neuron Biomedical to be Possible Value Trap.

Key valuation signals for ROCO:6973:

  • Notes Receivable: NT$0.00 Mil
  • GF Value™: NT$70.22 vs. price of NT$41.35 (41.1% below fair value)
  • GF Score™: 32/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6973 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

U-Neuron Biomedical Business Description

Address Xintai 5th Road, 18th Floor-5, No. 99, Section. 1, Xizhi District, New Taipei City, TWN, 22175
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
32GF Score

Get the complete analysis for ROCO:6973

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$41.35
Price
NT$70.22
GF Value